A team of researchers from Dow University of Health Sciences (DUHS) claimed to have made a major breakthrough in Monday's treatment of Covid-19 after producing intravenous immunoglobulin (IVIG) with plasma obtained from recovered coronavirus patients.
Dow University of health sciences DUHS director Muhammad Saeed Quraishy said it is a major breakthrough in the battle against Covid-19, according to a university press release by DUHS. This type of medication is safe, low-risk, and highly beneficial against coronavirus infection.
This method produces immunoglobulin after secretion of antibodies in the blood of a recovered patient," the statement states that the treatment has been approved by the US Food and Drug. Administration.
The university called its efforts "a bright spot in this time of crisis" and added that the research team led by Dr. Shaukat Ali developed this treatment after the first blood sample was taken from an infected patient in March.
The team succeeded in chemically isolating, purifying and later concentrating antibodies from the blood sample using ultrafiltration techniques that remove residual unwanted materials from the final product," added the treatment statement.
The university was convinced of the effectiveness of its treatment and noted that the Covid-19 strain currently infecting Pakistanis has 'few mutations' and therefore the local IVIG of infected patients is an extremely effective form of immunization against Covid. -19. for Pakistanis.
Last week, university researchers discovered that certain variants of a human gene may offer resistance to the new coronavirus, also known as SARS-CoV-2.
